U.S., May 24 -- ClinicalTrials.gov registry received information related to the study (NCT06987851) titled 'An Extension Clinical Study of the Efficacy and Safety of BCD-132 in Patients With Multiple Sclerosis Who Previously Received Therapy in Clinical Studies of JSC BIOCAD' on May 16.
Brief Summary: The aim of this clinical study is to assess the long-term efficacy and safety of BCD-132 (divozilimab) in patients with multiple sclerosis who previously participaded in BCD-132-2 and BCD-132-4/MIRANTIBUS studies
Study Start Date: March 22, 2022
Study Type: INTERVENTIONAL
Condition:
Multiple Sclerosis
Intervention:
BIOLOGICAL: Divozilimab
Intravenous infusion of BCD-132 every 24 weeks
Recruitment Status: COMPLETED
Sponsor: Biocad
Pu...